Jacob Raber received his B.Sc. in Chemistry and M.Sc. in Pharmacochemistry from the Free University of Amsterdam with a B.Sc. in Chemistry and his Ph.D. in Molecular Genetics and Virology from the Weizmann Institute of Science. From 1991 to 1996, he was a postdoctoral fellow at the Scripps Research Institute. From 1996 to 2001, he was an Adjunct Assistant Professor/Staff Research Scientist at the Gladstone Institute of Neurological Disease. In 2001, he was recruited to Oregon Health & Science University (OHSU) in Portland, Oregon. He is a professor in the Departments of Behavioral Neuroscience, Neurology, Psychiatry, and Radiation Medicine, an affiliate scientist in the Division of Neuroscience at the ONPRC, and a Courtesy Professor in the College of Pharmacy at Oregon State University. He was an Ellison Medical Foundation New Scholar in Aging from 2002 to 2006. His research is devoted to characterizing the effects of environmental and genetic factors on brain function, identifying affected pathways, and developing treatments to antagonize detrimental effects.
Jacob Raber received his B.Sc. in Chemistry and M.Sc. in Pharmacochemistry from the Free University of Amsterdam with a B.Sc. in Chemistry and his Ph.D. in Molecular Genetics and Virology from the Weizmann Institute of Science. From 1991 to 1996, he was a postdoctoral fellow at the Scripps Research Institute. From 1996 to 2001, he was an Adjunct Assistant Professor/Staff Research Scientist at the Gladstone Institute of Neurological Disease. In 2001, he was recruited to Oregon Health & Science University (OHSU) in Portland, Oregon. He is a professor in the Departments of Behavioral Neuroscience, Neurology, Psychiatry, and Radiation Medicine, an affiliate scientist in the Division of Neuroscience at the ONPRC, and a Courtesy Professor in the College of Pharmacy at Oregon State University. He was an Ellison Medical Foundation New Scholar in Aging from 2002 to 2006. His research is devoted to characterizing the effects of environmental and genetic factors on brain function, identifying affected pathways, and developing treatments to antagonize detrimental effects.